Outcome | DEX (nĀ =ā44) | Usual care (nĀ =ā39) | Estimate (95%CI) | p value |
---|---|---|---|---|
Difference in medians | ||||
āNEq dosea, Ī¼g/kg/min | 0.03 [0.01, 0.07] | 0.04 [0.01, 0.16] | āā0.01 [āā0.06, 0.04] | 0.17 |
āNoradrenaline dosea, Ī¼g/kg/min | 0.03 [0.01, 0.07] | 0.05 [0.01, 0.15] | āā0.01 [āā0.06, 0.03] | 0.08 |
āCumulative NEq dosea, Ī¼g/kg/48āh. | 1.51 [0.51, 3.60] | 2.14 [0.58, 7.78] | āā0.62 [āā3.18, 1.93] | 0.19 |
āPeak NEq dosea, Ī¼g/kg/min | 0.12 [0.05, 0.20] | 0.16 [0.08, 0.32] | āā0.03 [āā0.12, 0.06] | 0.24 |
āChange in NEq dose from baseline to peak levela, Ī¼g/kg/min | 0.05 [0.01, 0.12] | 0.05 [0.01, 0.14] | āā0.01 [āā0.06, 0.05] | 0.61 |
āTotal duration of vasopressor supportb, h | 51.6 [18.3, 99.7] | 45.7 [19.6, 159.0] | 3.1 [āā30.7, 36.9] | 0.72 |
āāSurvivors (nĀ =ā67) | 35.6 [18.3, 69.4] | 40.3 [22.2, 75.6] | āā3.5 [āā30.1, 23.1] | 0.64 |
āāNon-survivors (nĀ =ā16) | 186.0 [59.0, 311.0] | 70.4 [19.4, 168.0] | 19.8 [āā173.1, 212.6] | 0.42 |
āDuration of invasive ventilationb, days | 2.2 [1.1, 5.9] | 2.8 [1.2, 9.6] | āā0.5 [āā3.8, 2.8] | 0.60 |
āHospital length of stayb, days | 15.5 [9.4, 24.4] | 13.2 [7.7, 21.0] | āā2.2 [āā8.5, 4.1] | 0.30 |
āICU length of stayb, days | 4.2 [2.7, 10.2] | 4.7 [3.0, 11.3] | āā0.4 [āā3.4, 2.6] | 0.67 |
āāSurvivors (nĀ =ā67) | 4.1 [3.0, 9.2] | 4.3 [3.2, 7.0] | āā0.1 [āā2.7, 2.3] | 0.70 |
āāNon-survivors (nĀ =ā16) | 8.9 [2.4, 16.2] | 8.3 [0.8, 11.3] | āā3.3 [āā16.2, 9.6] | 0.87 |
Odds ratio (95% CI) | ||||
āPatients alive and vasopressor-free at 48āh after randomization | 20 (45.5) | 18 (46.2) | 0.97 (0.41ā2.31) | 0.95 |
āICU mortality | 6 (13.6) | 10 (25.6) | 0.46 (0.15ā1.41) | 0.17 |
āHospital mortality | 9 (20.5) | 12 (30.8) | 0.58 (0.21ā1.57) | 0.28 |
āDay 90 mortality | 12 (27.3) | 13 (34.2) | 0.72 (0.28ā1.85) | 0.50 |